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Abstract
Objective—Traumatic brain injury (TBI) is increasingly recognized as a risk factor for 
deleterious mental health and functional outcomes. The purpose of this study was to examine the 
strength and specificity of the association between deployment-acquired TBI and subsequent 
posttraumatic stress and related disorders among U.S. Army personnel.
Method—A prospective, longitudinal survey of soldiers in three Brigade Combat Teams was 
conducted 1–2 months prior to an average 10-month deployment to Afghanistan (T0), upon 
redeployment to the United States (T1), approximately 3 months later (T2), and approximately 9 
months later (T3). Outcomes of interest were 30-day prevalence postdeployment of posttraumatic 
stress disorder (PTSD), major depressive episode, generalized anxiety disorder, and suicidality, as 
well as presence and severity of postdeployment PTSD symptoms.
Results—Complete information was available for 4,645 soldiers. Approximately one in five 
soldiers reported exposure to mild (18.0%) or more-than-mild (1.2%) TBI(s) during the index 
deployment. Even after adjusting for other risk factors (e.g., predeployment mental health status, 
severity of deployment stress, prior TBI history), deployment-acquired TBI was associated with 
elevated adjusted odds of PTSD and generalized anxiety disorder at T2 and T3 and of major 
depressive episode at T2. Suicidality risk at T2 appeared similarly elevated, but this association 
did not reach statistical significance.
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Conclusions—The findings highlight the importance of surveillance efforts to identify soldiers 
who have sustained TBIs and are therefore at risk for an array of postdeployment adverse mental 
health outcomes, including but not limited to PTSD. The mechanism(s) accounting for these 
associations need to be elucidated to inform development of effective preventive and early 
intervention programs.
Mild traumatic brain injury (mild TBI; also known as concussion), previously believed to be 
an almost uniformly benign event, has garnered increased attention as a potential source of 
adverse neuropsychological outcomes in civilians (e.g., athletes who play contact sports) and 
military personnel alike (1–4). With respect to mental health outcomes, many observational 
studies—the earliest from military settings (5, 6)—have established an association between 
mild TBI and posttraumatic stress disorder (PTSD) (7–15). Although most of these studies 
have been cross-sectional and/or retrospective in design, or have relied on hospitalized, 
treatment-seeking or other potentially nonrepresentative samples, a few studies of 
longitudinal prospective cohorts have clearly demonstrated an association between TBI and 
subsequent PTSD (15, 16).
Numerous questions about the association between TBI and PTSD remain unanswered. 
Among them are uncertainties about the specificity of this association. Is PTSD a unique or 
particularly prevalent outcome of TBI, or is risk of developing (certain) other mental 
disorders comparable? A civilian study of 1,084 traumatically injured individuals found that 
TBI was a strong risk factor not only for PTSD but also for a wide range of depressive and 
anxiety disorders (16). Another area of controversy pertains to the importance of the severity 
of TBI, particularly with regard to whether “very mild” (i.e., dazed but no loss of 
consciousness or amnesia) TBIs have a salient impact on subsequent mental health. To the 
best of our knowledge, neither of these questions has been addressed in a large, prospective 
longitudinal cohort and never in a military setting. The present study uses data from the Pre/
Post Deployment Study (PPDS), a prospective, longitudinal component of the Army Study 
to Assess Risk and Resilience in Servicemembers (Army STARRS) (17), to examine the 
relationships of deployment-acquired TBI with postdeployment PTSD and related disorders, 
controlling for a range of other known and hypothesized pre- and peri-deployment predictors 
of these outcomes.
METHOD
Overview of the PPDS of Army STARRS
Detailed information about the design and conduct of Army STARRS is available in a 
separate report (17). The PPDS of Army STARRS is a multiwave panel survey that collected 
baseline data (T0; self-administered questionnaire) from U.S. Army soldiers in three Brigade 
Combat Teams during the first quarter of 2012, within approximately 6 weeks of their 
deployment to Afghanistan. Follow-up data were collected from these same respondents at 
three times after they returned from deployment: within 1 month of their return (T1; self-
administered questionnaire and blood samples), approximately 3 months later (T2; self-
administered questionnaire), and 9 months later (T3; self-administered questionnaire). The 
baseline (T0) questionnaire was an extensive survey of socio-demographic characteristics, 
lifetime and past-30-day mental disorders, and a panoply of potential risk and resilience 
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factors, including but not limited to past civilian and military experiences. The T1 follow-up 
questionnaire included only a brief assessment of experiences that occurred during 
deployment (including deployment stressors and TBI). The T2 and T3 questionnaires, which 
were virtually identical, were more extensive, covering mainly intercurrent experiences 
subsequent to the prior assessments.
The PPDS study population consisted of all soldiers in three Brigade Combat Teams that 
deployed to Afghanistan (average duration of deployment was 10 months) shortly after 
completing the baseline (T0) PPDS data collection. All participants gave their informed, 
written consent to participate. Baseline PPDS respondents were additionally asked for 
consent to provide blood samples, to link their Army and Department of Defense 
administrative records to their survey responses, and to participate in future assessments. 
Similar informed consent procedures were used in the postdeployment data collections. 
These procedures were approved by the human subjects committees of all collaborating 
organizations.
At the baseline (T0), a total of 9,949 soldiers were present for duty in the three Brigade 
Combat Teams. Of these, a total of 9,488 (95.3%) consented to participate in the survey with 
8,558 (86.0%) providing complete T0 survey responses and consent to link their survey 
responses to their administrative records. The T0 longitudinal analysis cohort for this 
investigation was restricted to the subpopulation (N=7,742) of these T0 study participants 
who subsequently deployed to Afghanistan. A total of 4,645 (60.0%) of the 7,742 T0 study 
participants that deployed to Afghanistan provided complete data at all three 
postdeployment assessments (i.e., T1, T2, and T3). To compensate for T1, T2, and/or T3 
attrition losses from the eligible baseline sample of 7,742 participants, response propensity 
(based on T0 measures available for all baseline respondents) and poststratification (based 
on comparisons of distributions for key socio-demographic and Army career variables from 
administrative data available for the entire Army as well as for survey respondents) 
weighting factors (18) were developed and applied in all analyses of the multiwave data.
Measures
Diagnostic assessment—At baseline (T0), PPDS respondents self-administered a 
computerized version of the Composite International Diagnostic Interview screening scales 
(CIDI-SC) (19) and a 6-item screening version of the PTSD Checklist (20) to assess 10 
lifetime DSM-IV mental disorders. Diagnoses were made without DSM-IV diagnostic 
hierarchy or organic exclusion rules. The sum of all past-30-day depression, anxiety, and 
irritability items from the screening scales (24 items, each ranging 0–4) was also used to 
create a general distress score (range: 0–96). As reported in detail elsewhere (21), an Army 
STARRS clinical reappraisal study found satisfactory concordance between CIDI-SC and 
modified PTSD Checklist diagnoses and independent clinical diagnoses based on blinded 
Structured Clinical Interviews for DSM-IV (area under receiver operating characteristic 
curve=0.70–0.79; κ=0.4–0.6).
These measures were repeated approximately 3 months (T2) and 9 months (T3) after 
redeployment to the United States. The full 17-item PTSD Checklist was administered at T2 
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and T3. In this sample, 6-item PTSD Checklist scores correlated highly (T2: r=0.96; T3: 
r=0.96) with PTSD Checklist (i.e., 17-item) scores.
Suicidality—Suicidal behaviors were assessed using a modified version of the Columbia-
Suicide Severity Rating Scale (22) assessing lifetime occurrence and age at onset of suicide 
ideation and, among respondents who reported lifetime ideation, suicide plans and attempts. 
Lifetime (or past-30-day) suicidality was determined at T0 as endorsing lifetime (or past-30-
day) suicidal ideation, plans, and/or attempt(s). Past-30-day suicidality was assessed at T2 
and T3 using the same questions.
Deployment stress—The T1 survey included 15 questions that assessed the frequency of 
stressful deployment experiences (e.g., During your deployment how many times did you 
…. Go on combat patrols or have other dangerous duty? [e.g., route clearance, clearing 
buildings, disarming civilians, working in areas that had IEDs] or …. Fire rounds at the 
enemy or take enemy fire? [either direct or indirect fire]). Responses to these questions were 
discretized (yes/no), and positive responses were summed to create a total (0–15) 
deployment stress severity score.
TBI status—Probable TBI was determined by the probe (How many times during your 
recent deployment did you have a head, neck, or blast injury that…?) followed by a series of 
questions pertaining to subsequent alteration or loss of consciousness and lapse of memory. 
We used the highest level of severity of response(s) to characterize each respondent as 
having had one of the following: 1) No TBI; 2) probable “very mild” TBI (alteration but no 
loss of consciousness [“didn’t knock you out but caused you to be dazed or ‘see stars’”] and 
no lapse of memory); 3) probable “mild TBI” (loss of consciousness [“knocked you out”] 
for less than 30 minutes and/or lapse of memory for less than 30 minutes); or 4) probable 
“more-than-mild TBI” (loss of consciousness for 30 minutes or more or lapse in memory 
lasting 30 minutes or more). Using these criteria, TBIs classified as “very mild” or “mild” 
would match up with most standard and widely used definitions of mild TBI (e.g., http://
tbilaw.com/acrm-brain-injury-definition.html). The majority of TBIs classified as “more-
than-mild” would fall into a higher category of clinical severity, although cases in this 
category defined by loss of consciousness <30 minutes and posttraumatic amnesia <24 hours 
could fall within standard definitions of mild TBI (hence our labeling of this category as 
probable “more-than-mild”). We evaluated the effects of the various levels of severity, as 
well as “any” deployment-acquired TBI (or lifetime TBI prior to the index deployment) 
compared with none.
We also attempted to corroborate our survey reporting of TBIs with the Army’s own TBI 
surveillance as a component of the Pre- or Post-Deployment Health Reassessment (http://
www.armyg1.army.mil/hr/pdhra/), which, it should be noted, is also based on self-report. 
Data showing the concordance between these two modes of self-assessment are presented in 
the online data supplement accompanying this article.
Socio-demographic variables—Socio-demographic variables considered here were 
age, sex, ethnicity, and race.
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Analysis methods—We conducted a series of logistic regression analyses where 
deployment-acquired TBI (1=any, 0=none, assessed at T1) or severity of deployment-
acquired TBI (none versus very mild versus mild versus more-than-mild) was the predictor 
of primary interest and past 30-day, postdeployment mental health disorders or indicators 
(assessed at T2 and T3) were the outcome(s). Models adjusted for factors that we thought 
might influence risk for TBI as well as have independent associations with the outcomes, 
including age (≤30 versus older), sex, ethnicity, race, Brigade Combat Team, predeployment 
(T0) mental health status, number of prior deployments (none versus one versus two or 
more), and severity of deployment stress. Duration of index deployment was included in 
earlier models but found to be entirely nonpredictive, and thus it was excluded from the final 
models. We also conducted zero-inflated negative binomial regression analyses to jointly 
model the effect of deployment-acquired TBI on presence (yes/no) and severity (for nonzero 
scores) of PTSD symptoms as measured by the PTSD Checklist.
All analyses were weighted to account for T1, T2, and T3 survey attrition from the eligible 
T0 soldier cohort. Since the PPDS data are both clustered by Brigade Combat Team and 
administration session and weighted, the design-based Taylor series linearization method 
was used to produce standard errors. Multivariate significance was examined using design-
based Wald chi-square tests. All statistical analyses were conducted using the software R 
(version 3.0.2, R Development Core Team, 2011). Additionally, p values <0.05 (two-tailed) 
were considered statistically significant.
RESULTS
Participant Characteristics at Predeployment Baseline (T0)
All reported percentages and means are weight-adjusted. The sample was predominantly 
male (94.7% [SE=0.6%]) and less than 30 years of age (71.6% [SE=1.4%]). The majority of 
participants were White (71.8% [SE=0.8%]), with smaller proportions identifying their race 
as Other (12.2% [SE=0.6%]), Black (12.0% [SE=0.7%]), and Asian (4.0% [SE=0.3%]), and 
16.1% (SE=0.6%) identifying their ethnicity as Hispanic. For 44.8% (SE=1.2%) of soldiers, 
the index deployment to Afghanistan was their first, with others reporting one (23.3% 
[SE=0.7%]) or multiple (31.8% [SE=1.1%]) previous deployments.
Estimated lifetime prevalence of mental disorders at the baseline (T0) interview was 12.0% 
(SE=0.6%) for PTSD, 9.3% (SE=0.6%) for major depressive episode, 8.3% (SE=0.4%) for 
generalized anxiety disorder, and 10.7% (SE=0.5%) for suicidality. Prior to deployment, 
mean PTSD symptom severity as measured by the 6-item PTSD Checklist was 7.87 
(SD=3.49; median=6, range=6–30, interquartile range=6–8), and mean general distress was 
11.03 (SD=14.51; median=6, range=0–96, interquartile range=2–13).
Approximately one-third of soldiers reported having sustained TBI(s) prior to the index 
deployment (T0), with 14.8% (SE=0.6%) endorsing one and 19.5% (SE=0.8%) endorsing 
two or more lifetime TBIs.
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Deployment Stress and Deployment-Acquired TBI
The mean number of deployment stressors in the index deployment endorsed by respondents 
at T1 was 4.02 (SD=2.76; median=4, range=0–15, interquartile range=2–6). Approximately 
1 in 5 soldiers reported exposure to TBI(s) during the index deployment, with 13.2% 
(SE=0.6%) endorsing probable very mild TBI (i.e., dazed only, no loss of consciousness or 
amnesia), 4.8% (SE=0.4%) endorsing probable mild TBI, and 1.2% (SE=0.2%) endorsing 
probable more-than-mild TBI.
Mental Health Outcomes at 3 Months Postdeployment (T2)
At the T2 follow-up, approximately 3 months postredeployment to the United States from 
Afghanistan, past-30-day DSM-IV PTSD was reported by 7.8% (SE=0.5%) of soldiers. The 
mean PTSD Checklist score at T2 was 24.80 (SD=10.78; median=21, range=17–85, 
interquartile range=17–28).
Past-30-day prevalence of other mental disorders at T2 was 6.8% (SE=0.4%) for major 
depressive episode, 4.8% (SE=0.3%) for generalized anxiety disorder, and 2.9% (SE=0.2%) 
for suicidality. The combined prevalence of any past-30-day PTSD, major depressive 
episode, generalized anxiety disorder, or suicidality at T2 was 12.9% (SE=0.6%; see Figure 
1 for depiction of comorbidity rates). The mean general distress score at T2 was 11.97 
(SD=16.02; median=6, interquartile range=1–15).
Association of deployment-acquired TBI with posttraumatic stress outcomes
—In a logistic regression analysis adjusting for age group, sex, ethnicity, race, Brigade 
Combat Team, number of prior deployments, predeployment TBI history, lifetime PTSD 
predeployment, PTSD symptoms at baseline (6-item PTSD Checklist score at T0), and 
deployment stress severity, deployment-acquired TBI was strongly associated with increased 
odds of postdeployment (T2) past-30-day PTSD (adjusted odds ratio=1.81, 95% CI=1.32–
2.46, p<0.0005; see Table 1).
The above model was rerun stratifying TBI-positive subjects into those with probable “very 
mild,” “mild,” and “more than mild” concussions. Whereas all TBI-positive groups 
displayed increased odds for past 30-day PTSD at T2, a dose-response relationship was 
observed whereby odds of PTSD increased as TBI severity worsened (adjusted odds 
ratios=1.66, 1.76, and 3.90 for “very mild,” “mild,” and “more-than-mild,” respectively; 
p<0.0005).
Whereas the previous models evaluated presence or absence of PTSD as a dichotomous 
outcome, we also evaluated whether deployment-acquired TBI was associated with 
increased PTSD symptoms at T2. Having sustained a TBI during the index deployment was 
associated with increased odds of a nonzero score on the PTSD Checklist (i.e., having some 
PTSD symptoms versus none; adjusted odds ratio=1.47, 95% CI=1.03–2.08, p=0.04) and a 
1.35-fold increase in PTSD Checklist score when symptoms were present (i.e., when the 
PTSD Checklist score was nonzero; fold change=1.35, 95% CI=1.21–1.51, p<0.001; see 
Table 2).
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Association of deployment-acquired TBI with other mental health outcomes—
In logistic regression analyses adjusting for age group, sex, ethnicity, race, Brigade Combat 
Team, number of prior deployments, lifetime history of the outcome in question (major 
depressive episode, generalized anxiety disorder, or suicidality) predeployment (T0), general 
distress predeployment (T0), and deployment stress severity, deployment-acquired TBI was 
associated with postdeployment (T2) risk of past-30-day major depressive episode (adjusted 
odds ratio=1.45, 95% CI=1.02–2.04, p=0.037) and generalized anxiety disorder (adjusted 
odds ratio=1.81, 95% CI=1.21–2.70, p=0.004). The association between deployment-
acquired TBI and past-30-day suicidality did not reach the threshold for statistical 
significance (adjusted odds ratio=1.39, 95% CI=0.97–2.01, p=0.076).
Deployment-acquired TBI was associated with increased odds of the composite of any of 
these past-30-day outcomes (adjusted odds ratio=1.74, 95% CI=1.33–2.27, p<0.0005; see 
Table 3). When the composite outcome was rerun stratifying TBI-positive subjects into those 
with probable “very mild,” “mild,” and “more than mild” concussions, a dose-response 
relationship between severity of TBI and odds of the composite outcome was observed 
(adjusted odds ratios=1.57, 1.78, and 4.28 for “very mild,” “mild,” and “more than mild,” 
respectively; p<0.0005).
Mental Health Outcomes at 9 Months Postdeployment (T3)
At the T3 follow-up, approximately 9 months postredeployment to the United States from 
Afghanistan, past-30-day DSM-IV PTSD was reported by 11.7% (SE=0.5%) of soldiers. 
The mean PTSD Checklist score at T3 was 25.79 (SD=12.70; median=19, interquartile 
range=17–30).
Past-30-day prevalence of other mental disorders at T3 was 6.7% (SE=0.3%) for major 
depressive episode, 6.2% (SE=0.4%) for generalized anxiety disorder, and 5.7% (SE=0.4%) 
for suicidality. The combined prevalence of any past-30-day PTSD, major depressive 
episode, generalized anxiety disorder, or suicidality at T3 was 16.8% (SE=0.6%; see Figure 
2 for depiction of comorbidity rates). The mean general distress score at T3 was 14.32 
(SD=18.12; median=6, interquartile range=2–21).
Association of deployment-acquired TBI with posttraumatic stress outcomes
—In a logistic regression analysis adjusting for age group, sex, ethnicity, race, Brigade 
Combat Team, number of prior deployments, predeployment TBI history, lifetime PTSD 
predeployment, PTSD symptoms at baseline (6-item PTSD Checklist score at T0), and 
deployment stress severity, deployment-acquired TBI was strongly associated with increased 
odds of past-30-day PTSD at 9 months postdeployment (T3) (adjusted odds ratio=1.48, 95% 
CI=1.21–1.83, p<0.0005; see Table 1).
When the above model was rerun stratifying TBI-positive subjects into those with probable 
“very mild,” “mild,” and “more-than-mild” concussions, a dose-response relationship with 
TBI severity was seen such that increasing severity of TBI was associated with increasing 
odds of T3 past-30-day PTSD (adjusted odds ratios=1.21, 1.78, and 4.49 for “very mild,” 
“mild,” and “more than mild,” respectively; p<0.0005). However, the adjusted odds ratio for 
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“very mild TBI” (1.21) was not significantly elevated relative to the “no TBI” reference 
group (p=0.13).
Whereas the previous models evaluated presence or absence of PTSD as a dichotomous 
outcome, we also evaluated whether deployment-acquired TBI was associated with 
increased PTSD symptoms at T3. Having sustained a TBI during the index deployment was 
associated with increased odds of a nonzero score on the PTSD Checklist (i.e., having some 
PTSD symptoms versus none; adjusted odds ratio=1.82, 95% CI=1.22–2.70, p=0.005) and a 
1.20-fold increase in PTSD Checklist score when symptoms were present (i.e., when the 
PTSD Checklist score was nonzero; fold change=1.20, 95% CI=1.10–1.31, p<0.001; see 
Table 2).
Association of deployment-acquired TBI with other mental health outcomes—
In logistic regression analyses adjusting for age group, sex, ethnicity, race, Brigade Combat 
Team, number of prior deployments, lifetime history of the outcome in question (major 
depressive episode, generalized anxiety disorder, or suicidality) predeployment (T0), general 
distress predeployment (T0), and deployment stress severity, deployment-acquired TBI was 
associated with postdeployment (T3) risk of past-30-day generalized anxiety disorder 
(adjusted odds ratio=1.81, 95% CI=1.21–2.70, p<0.0005). The association of deployment-
acquired TBI with T3 past-30-day major depressive episode did not reach statistical 
significance (adjusted odds ratio=1.28, 95% CI=0.97–1.69, p=0.08), nor was its association 
with T3 past-30-day suicidality significant (adjusted odds ratio=1.12, 95% CI=0.86–1.46, 
p=0.40).
Deployment-acquired TBI was associated with the composite of any of these outcomes at T3 
(adjusted odds ratio=1.53, 95% CI=1.29–1.82, p<0.0005; see Table 3). When the composite 
outcome was rerun stratifying TBI-positive subjects into those with probable “very mild,” 
“mild,” and “more-than-mild” concussions, a dose-response relationship with TBI severity 
was seen such that increasing severity of TBI was associated with increasing odds of T3 
past-30-day composite of these outcomes (adjusted odds ratios=1.28, 1.87, and 4.22, 
p<0.0005, for “very mild,” “mild,” and “more than mild,” respectively).
DISCUSSION
Consistent with studies of individuals who sustained traumatic injury in civilian settings (16, 
23, 24), we found evidence from this large, prospective military cohort study that 
deployment-acquired TBI is associated with substantially increased risk for having PTSD at 
3 and 9 months postdeployment. This association was robust across models that adjusted for 
multiple concurrent risk factors (particularly lifetime PTSD, baseline PTSD symptoms, prior 
TBI history and deployment stress severity) and that considered multiple indicators of the 
outcome of interest (PTSD diagnosis; presence and severity of PTSD symptoms). These 
findings converge with results of considerable observational research that has shown mild 
TBI to be among the most salient risk factors for the development of PTSD (3, 14, 15).
Few studies have attempted to investigate the impact of TBI severity on subsequent mental 
health outcomes. However, a recent study of military personnel found that blast-related mild 
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TBI with loss of consciousness (versus no loss of consciousness) was associated with 
increased risk for PTSD (25). An Israeli study of civilian motor vehicle collision survivors 
with head injuries similarly found that the risk of PTSD was increased if the injury included 
loss of consciousness (26). We found a dose-response relationship between “very mild” 
(dazed but no loss of consciousness or amnesia), “mild” (some loss of consciousness or 
amnesia), and “more-than-mild” TBI and the observed outcomes. More-than-mild TBI was 
associated with the greatest elevations of risk for PTSD and the composite outcome of any 
PTSD, major depressive episode, generalized anxiety disorder, or suicidality, with odds 
ratios reflecting approximately 4 times greater risk relative to those without deployment-
acquired TBI. Mild TBI conveyed an intermediate elevation of risk for the same outcomes, 
with odds ratios suggesting a near-doubling of risk relative to those without deployment-
acquired TBI. Very mild TBI was also associated with increased odds of PTSD and the 
composite outcome; however, the elevation of risk was smaller in magnitude (range of 
adjusted odds ratios=1.21–1.66) and, in the case of PTSD, was only statistically significant 
at T2.
Some TBI studies suggest that memory of the traumatic event increases risk for PTSD (27). 
Our results stand in contrast with that observation, in that risk for PTSD became more 
elevated as TBI severity (including extent of amnesia) increased. The impact of trauma 
memory on PTSD risk merits further study; however, it seems clear that PTSD can, indeed, 
occur after TBI characterized by incomplete or partial memories of the injury or postinjury 
period (including dis-orienting and painful medical procedures, such as those that may occur 
during intensive care unit stays) (28).
The present findings related to TBI severity further suggest that extent of injury to the brain 
moderates the likelihood of the development of mental health sequelae. This is hardly a 
radical notion, as considerable neuroimaging and neuropsychological research supports a 
model wherein TBI impairs functioning of prefrontocortical and networked systems that are 
believed to be integral for inhibiting fear responses and promoting fear extinction (29). But 
there also exists a contrarian view that concussions increase risk for mental disorders not by 
virtue of their mechanical impact on the brain, per se, but rather by their emotional impact 
on the individual’s psyche as a result of their occurrence within a potentially life-threatening 
and otherwise stressful context (i.e., military combat) (30). Which of these accounts is most 
true—and it is likely that both have explanatory power—remains to be determined by future 
studies that can more accurately gauge these factors (i.e., extent of physical and emotional 
injury) and disaggregate their effects.
Another important finding from the present study is the observation that whereas PTSD is, 
indeed, a frequent consequence of deployment-acquired TBI, so are other mental disorders. 
In addition to PTSD, postdeployment major depressive episode and generalized anxiety 
disorder were both significantly associated with deployment-acquired TBI. These data are 
again consistent with the aforementioned study of civilian traumatic injury survivors (16), 
where TBI was associated with increased incidence of multiple psychiatric disorders. These 
observations highlight the myriad mental health sequelae of TBI (29) and indicate that 
surveillance must extend beyond the relatively narrow framework of PTSD. It is evident that 
mental disorder incidence following TBI is sufficiently high that routine screening might be 
Stein et al. Page 9
Am J Psychiatry. Author manuscript; available in PMC 2016 November 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
worth implementing (7), but precisely if, how, and when to conduct such screening remains 
to be empirically determined. Moreover, researchers have begun to recognize that symptoms 
and impairment post-TBI do not neatly fall into any one diagnostic psychiatric or neurologic 
(including postconcussive syndrome) category (23) and that much additional work will be 
needed to characterize and classify the full and complex range of cognitive, emotional, and 
behavioral symptoms that can occur.
Suicidality has until very recently been an understudied potential consequence of TBI. A 
large Swedish population-based study found that TBI was associated with a threefold 
increased risk of suicide compared with the adjusted risk in the general population (31). A 
study of 161 U.S. military personnel referred to a TBI clinic in Iraq for suspected head 
injury found that multiple episodes of TBI, which were common among U.S. military 
personnel, were associated with increased risk for lifetime suicidal thoughts and behaviors, 
as well as for current suicidal ideation (11). Baseline assessment of the Veterans After-
Discharge Longitudinal Registry (Project VALOR), an observational registry of over 1,600 
veterans with and without PTSD who deployed in support of the wars in Iraq and 
Afghanistan and were enrolled in the Veterans Affairs health care system, found that a 
history of TBI was associated with increased risk for current suicidal ideation, though only 
in men (9). The present longitudinal cohort study failed to clearly demonstrate an increase in 
risk for suicidality in individuals who sustained TBI during deployment. Whereas a modest, 
nearly significant association was seen at 3 months postdeployment, by the 9-month follow-
up this association was no longer evident. It may be that suicidality should be a greater 
concern for the first few months postconcussion but that this risk may wane with time. 
Additional longitudinal research will be required to resolve this question. Thus, although 
inconclusive, these data call for increased attention to TBI, along with what is already 
known about other susceptibility factors such as pre-existing mental disorders (32, 33), as a 
potentially modifiable risk factor for suicide among military personnel.
Strengths of this study are its large sample size and its detailed, systematic longitudinal 
prospective assessment of three Army Brigade Combat Teams about to be deployed to 
Afghanistan. A limitation is that diagnostic data were collected by self-report rather than by 
direct clinical interviews, but this is mitigated by the extensive testing and clinical 
calibration of our diagnostic measures (21). A second limitation is that information about the 
main exposure of interest, TBI, was obtained by self-report and further lacked specification 
about presumed mechanism of injury (e.g., blast versus impact). Studies show, however, that 
mild TBIs are often medically undiagnosed (1, 34) or underreported (35), and our own 
attempts to corroborate TBI self-reports with military medical records revealed poor 
concordance (data not shown). The presence of a dose-response relationship between 
severity of self-reported TBI—even within the mild spectrum—and the outcomes of interest 
provides some re-assurance that the observed associations are valid. Nonetheless, future 
studies that can more deliberately and deeply debrief participants about the circumstances of 
their TBI(s) are needed. A third limitation is that the nature of our survey, wherein we 
tracked soldiers within their Brigade Combat Teams, would have resulted in very few cases 
of moderate or severe TBI being included, as many if not most of those soldiers would have 
been hospitalized and probably inaccessible to us for the follow-up assessments. 
Accordingly, it is important to recognize that this study is, essentially, a study of persons 
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with a range of TBI severity within the mild spectrum. A fourth limitation is the 
unavailability of survey data about other concurrent physical injury that respondents may 
have sustained. It is well established that extent and severity of physical injury increases risk 
for PTSD (36). It is therefore possible that those with TBIs may have also had more serious 
nonhead injuries than other soldiers and that an increased aggregate burden of injury may 
have contributed to the observed increase in PTSD and related disorders in those individuals. 
This hypothesis can be tested in future studies with access to more granular data about the 
type, timing, and extent of physical injuries sustained.
In summary, we found in this large, prospective cohort study of military personnel about to 
be deployed to Afghanistan that mild TBI is common during deployment and that it is 
associated with substantially increased risk for PTSD observed 3 and 9 months after 
redeployment to the United States. We also found that the risk for mental health problems 
following mild TBI is not restricted to PTSD, implying that the focus on surveillance and 
intervention needs to be broadened to include other anxiety and depressive disorders. 
Finally, the process(es) by which mild TBI increases risk for these disorders, which may 
include inflammatory or other neurodegenerative etiologies that impair brain network 
function (37–39), perhaps especially involving systems that mediate executive functioning 
(40), should be further studied in order to arrive at more mechanistic approaches to 
prevention and treatment.
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FIGURE 1. Comorbidity of Disorders Among Soldiers Classified at T2 (3 Months 
Postdeployment) as Experiencing Major Depressive Episode, Posttraumatic Stress Disorder, 
Generalized Anxiety Disorder, or Suicidality in the Past 30 Daysa
a
 Prevalence of any of these four outcomes at T2 was 12.9%.
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FIGURE 2. Comorbidity of Disorders Among Soldiers Classified at T3 (9 Months 
Postdeployment) as Experiencing Major Depressive Episode, Posttraumatic Stress Disorder, 
Generalized Anxiety Disorder, or Suicidality in the Past 30 Daysa
a
 Prevalence of any of these four outcomes at T3 was 16.8%.
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TABLE 1
Results of Weighted Logistic Regression Evaluating Effects of Deployment-Acquired Traumatic Brain Injury 
(TBI) on Posttraumatic Stress Disorder (PTSD) Diagnosis at 3 Months (T2) and 9 Months (T3) 
Postdeploymenta
3 Months Postdeployment (T2) 9 Months Postdeployment (T3)
Variable Adjusted
Odds Ratio
95% CI χ 2 p Adjusted
Odds Ratio
95% CI χ 2 p
Age (years) 0.51 0.48 0.56 0.45
 ≥30 1.00 1.00
 <30 0.90 0.66–1.21 1.10 0.86–1.40
Sex 2.73 0.10 11.69 0.001
 Male 1.00 1.00
 Female 1.58 0.92–2.72 2.11 1.37–3.23
Race 6.14 0.11 3.43 0.33
 White 1.00 1.00
 Black 0.97 0.60–1.58 1.06 0.67–1.66
 Asian 1.74 1.01–2.99 0.97 0.50–1.89
 Other 1.53 0.94–2.51 1.39 0.94–2.08
Ethnicity 0.79 0.37 0.48 0.49
 Non-Hispanic 1.00 1.00
 Hispanic 1.20 0.80–1.81 1.13 0.80–1.61
Brigade Combat Team 6.97 0.03 1.33 0.51
 Fort #1 1.00 1.00
 Fort #2 1.11 0.81–1.52 1.09 0.87–1.37
 Fort #3 1.55 1.11–2.18 0.98 0.75–1.27
Prior deployments 3.62 0.16 0.57 0.75
 None 1.00 1.00
 One 1.24 0.93–1.67 0.93 0.70–1.24
 Two or more 0.99 0.67–1.48 1.05 0.82–1.34
Lifetime PTSD (predeployment) 4.95 0.03 16.47 <0.0005
 No 1.00 1.00
 Yes 1.58 1.06–2.35 1.97 1.42–2.73
Past-month PTSD Checklist
 score (predeployment)
1.15 1.12–1.19 71.31 <0.0005 1.12 1.09–1.16 48.77 <0.0005
Deployment stress severity 1.28 1.20–1.36 63.95 <0.0005 1.19 1.15–1.23 113.10 <0.0005
Lifetime TBI (predeployment) 0.60 0.44 3.69 0.06
 None reported 1.00 1.00
 One or more reported 1.12 0.84–1.51 1.22 1.00–1.50
Deployment-acquired TBI 13.82 <0.0005 13.92 <0.0005
 None reported 1.00 1.00
 One or more reported 1.81 1.32–2.46 1.48 1.21–1.83
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a
Multivariate significance was evaluated using design-based Wald chi-square tests. The significance test for race had 3 degrees of freedom; the 
significance tests for Brigade Combat Team and prior deployments had 2 degrees of freedom; and the significance tests for all other independent 
variables had 1 degree of freedom.
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TABLE 3
Results of Weighted Logistic Regression Evaluating Effects of Deployment-Acquired Traumatic Brain Injury 
(TBI) on the Composite Outcome of Any Postdeployment Posttraumatic Stress Disorder (PTSD), Major 
Depressive Episode, Generalized Anxiety Disorder, or Suicidality at 3 Months (T2) and 9 Months (T3) 
Postdeploymenta
3 Months Postdeployment (T2) 9 Months Postdeployment (T3)
Variable Adjusted
Odds Ratio
95% CI χ 2 p Adjusted
Odds Ratio
95% CI χ 2 p
Age (years)
 ≥30 1.00 1.00
 <30 0.93 0.71–1.20 0.35 0.55 0.89 0.74–1.07 1.44 0.23
Sex
 Male 1.00 1.00
 Female 1.48 1.01–2.16 4.08 0.04 1.70 1.25–2.31 11.32 0.001
Race 4.55 0.21 4.44 0.22
 White 1.00 1.00
 Black 1.20 0.85–1.70 1.14 0.80–1.64
 Asian 1.17 0.73–1.87 0.67 0.40–1.11
 Other 1.36 0.94–1.97 1.21 0.88–1.65
Ethnicity 0.17 0.68 0.36 0.55
 Non-Hispanic 1.00 1.00
 Hispanic 1.08 0.75–1.55 1.09 0.82–1.45
Brigade Combat Team 17.63 <0.0005 8.25 0.02
 Fort #1 1.00 1.00
 Fort #2 1.30 0.98–1.72 1.25 1.04–1.49
 Fort #3 1.86 1.39–2.49 1.04 0.84–1.28
Prior deployments 1.69 0.43 1.21 0.55
 None 1.00 1.00
 One 1.07 0.87–1.31 0.93 0.77–1.14
 Two or more 0.90 0.67–1.21 0.90 0.74–1.11
Lifetime Diagnostic Composite
 (predeployment)b
37.35 <0.0005 55.13 <0.0005
 No 1.00 1.00
 Yes 2.42 1.82–3.21 2.43 1.92–3.06
Past-month general distress
 (predeployment)
1.04 1.03–1.05 121.96 <0.0005 1.02 1.02–1.03 58.60 <0.0005
Deployment stress severity 1.22 1.16–1.27 77.61 <0.0005 1.14 1.11–1.18 86.53 <0.0005
Lifetime TBI (predeployment) 0.04 0.85 4.21 0.04
 None reported 1.00 1.00
 One or more reported 1.02 0.82–1.28 1.22 1.01–1.47
Deployment-acquired TBI 16.67 <0.0005 24.13 <0.0005
 None reported 1.00 1.00
 One or more reported 1.74 1.33–2.27 1.53 1.29–1.82
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a
Multivariate significance was evaluated using design-based Wald chi-square tests. The significance test for race had 3 degrees of freedom; the 
significance tests for Brigade Combat Team and prior deployments had 2 degrees of freedom; and the significance tests for all other independent 
variables had 1 degree of freedom.
b
Diagnostic Composite refers to whether criteria were met for any of the following: PTSD, major depressive episode, generalized anxiety disorder, 
or suicidality.
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